Anakinra to Treat Patients With Neonatal Onset Multisystem Inflammatory Disease
A Long-Term Outcome Study With the IL-1 Receptor Antagonist Anakinra/Kineret in Patients With Neonatal Onset Multisystem Inflammatory Disease (NOMID/CINCA Syndrome) A Therapeutic Approach to Study the Pathogenesis of This Disease A Long-Term Outcome Study With the IL-1 Receptor Antagonist Anakinra/Kineret in Patients With Neonat ...
Nervous System Malformations;Arthropathy, Neurogenic;Urticaria;Papilledema
A long-term study with the IL-1 receptor blocker anakinra/kineret® in patients with neonatal onset multisystem inflammatory disease (NOMID/CINCA syndrome) A long-term study with the IL-1 receptor blocker anakinra/kineret® in patients with neonatal onset m ...
A long-term outcome study with the IL-1 receptor antagonist Anakinra/Kineret® in patients with Neonatal onset multisystem inflammatory disease (Nomid/Cinca syndrome) A long-term outcome study with the IL-1 receptor antagonist Anakinra/Kineret® in patients with Neona ...